KalVista Pharmaceuticals, Inc. Insider Transactions
KalVista Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 12,053 @ $14.11 | $170,124 | 72,895 | 02/20/2024 | 02/21/2024 | |
|
Palleiko Benjamin L
CFO, CBO |
Sell | 22,802 @ $14.11 | $321,846 | 187,315 | 02/20/2024 | 02/21/2024 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 14,295 @ $14.12 | $201,774 | 52,886 | 02/20/2024 | 02/21/2024 | |
| Sell | 24,888 @ $14.11 | $351,289 | 211,203 | 02/20/2024 | 02/21/2024 | ||
|
Palleiko Benjamin L
CFO, CBO |
Sell | 40,855 @ $15.01 | $613,205 | 159,088 | 02/14/2024 | 02/16/2024 | |
| Sell | 58,356 @ $15.01 | $875,883 | 181,676 | 02/14/2024 | 02/16/2024 | ||
|
Feener Edward P.
CHIEF SCIENTIFIC OFFICER |
Sell | 28,171 @ $15.01 | $422,827 | 71,657 | 02/14/2024 | 02/16/2024 | |
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 39,886 @ $15.01 | $598,661 | 66,160 | 02/14/2024 | 02/16/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 29,747 @ $14.70 | $437,281 | 4,824,731 | 02/08/2024 | 02/08/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 51,827 @ $14.56 | $754,601 | 4,794,984 | 02/07/2024 | 02/08/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 4,474 @ $14.74 | $65,947 | 4,743,157 | 02/06/2024 | 02/08/2024 | |
| Sell | 9,300 @ $16.18 | $150,428 | 118,232 | 02/01/2024 | 02/05/2024 | ||
| Sell | 700 @ $16.81 | $11,770 | 117,532 | 02/01/2024 | 02/05/2024 | ||
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 88,099 @ $14.47 | $1.27 M | 4,738,683 | 01/30/2024 | 02/01/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 80,600 @ $14.22 | $1.15 M | 4,650,584 | 01/29/2024 | 01/29/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 4,174 @ $12.98 | $54,179 | 4,569,984 | 01/26/2024 | 01/29/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 7,030 @ $12.73 | $89,492 | 4,565,810 | 01/25/2024 | 01/29/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 20,686 @ $12.44 | $257,334 | 4,558,780 | 01/24/2024 | 01/24/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 10,897 @ $12.54 | $136,648 | 4,538,094 | 01/23/2024 | 01/24/2024 | |
|
Venrock Healthcare Capital Partners III, L.P.
10 percent owner |
Buy | 67,546 @ $12.55 | $847,702 | 4,527,197 | 01/22/2024 | 01/24/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
KalVista Pharmaceuticals, Inc. FAQ's
The list of insiders at KalVista Pharmaceuticals, Inc. includes Palleiko Benjamin L, Audhya Paul K., Feener Edward P., Yea Christopher.
Insiders have sold a total of 136,809 KalVista Pharmaceuticals, Inc. shares in the last 12 months for a total of 1.54 M sold.
The following insiders have sold KalVista Pharmaceuticals, Inc. shares in the last 12 months: Palleiko Benjamin L ($738,089), Audhya Paul K. ($373,605), Feener Edward P. ($95,151), Yea Christopher ($331,614),